42Stockpicking

GILD

Gilead SciencesKøb· 83.1%· 20. aug. 2026
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
21,0
41st %ile · 62p
EV/EBITDAi
—
P/Bi
7,8
77th %ile · 64p
P/Si
7,2
71st %ile · 70p
EV/Salesi
8,3
74th %ile · 70p
Div yieldi
2,2 %
76th %ile · 39p

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 22.8.2026full
Prishistorik
30,3 år
Pris-dage
7626
Årsregnskaber
19
Peers
0/0
Valuation
5/6
Fundamentals
8/8
Datovindue
1996-04-30 til 2026-08-20

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

GILD vurderet 2026-08-22

Score
53.5%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

33%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

64%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

48%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

75%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

47%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

69%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

57%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 21.0 vs peer median 18.0; broadly in line with the peer set.

Insider activity

Net 90d (aktier)
-60.675
Net 90d (værdi)
-7.989.750 USD
Købere 90d
0
Cluster
—
DatoPersonRolleTypeAntalVærdiKilde
20.8.2026Bluestone Jeffrey—▼ SALG-1.165-167.474 USDsec
20.8.2026Bluestone Jeffrey—◆ OPT.1.16578.579 USDsec
17.8.2026Mercier JohannaChief Comm & Corp Aff Officer◆ OPT.23.1101.540.050 USDsec
17.8.2026Dickinson Andrew DChief Financial Officer▼ SALG-3.000-415.080 USDsec
17.8.2026Mercier JohannaChief Comm & Corp Aff Officer▼ SALG-16.530-2.270.643 USDsec
10.8.2026Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp◆ OPT.6.002—sec
10.8.2026Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp· ANDET-2.908-386.938 USDsec
3.8.2026O'Day Daniel PatrickChairman & CEO▼ SALG-6.700-868.711 USDsec
15.7.2026Dickinson Andrew DChief Financial Officer▼ SALG-3.000-389.777 USDsec
15.7.2026Mercier JohannaChief Comm & Corp Aff Officer▼ SALG-3.000-389.758 USDsec
1.7.2026O'Day Daniel PatrickChairman & CEO▼ SALG-11.900-1.500.467 USDsec
15.6.2026Mercier JohannaChief Comm & Corp Aff Officer▼ SALG-1.480-182.657 USDsec
15.6.2026Dickinson Andrew DChief Financial Officer▼ SALG-3.000-376.200 USDsec
10.6.2026Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp· ANDET-283-34.379 USDsec
10.6.2026Dickinson Andrew DChief Financial Officer◆ OPT.2.796—sec
10.6.2026Dickinson Andrew DChief Financial Officer· ANDET-1.341-162.905 USDsec
10.6.2026O'Day Daniel PatrickChairman & CEO◆ OPT.8.779—sec
10.6.2026O'Day Daniel PatrickChairman & CEO· ANDET-4.213-511.795 USDsec
10.6.2026Berger DietmarChief Medical Officer◆ OPT.533—sec
10.6.2026Berger DietmarChief Medical Officer· ANDET-263-31.949 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q230.7.2026-6,75-7,25+6.9%+6.9%Beat
2026Q130.4.20262,031,91+6.2%+6.2%Beat
2025Q430.1.20261,861,81+2.8%+2.8%Inline
2025Q330.10.20252,472,14+15.7%+15.7%Beat
2025Q230.7.20252,011,96+2.7%+2.7%Inline